MoneyWorks4Me

Sakar Healthcare - Quaterly Results

13 May 2026 Evaluate
The sales figure stood at Rs. 710.97 millions for the March 2026 quarter. The mentioned figure indicates a growth of about 41.51% as compared to Rs. 502.42 millions during the year-ago period.Profit for the quarter ended March 2026 rises by 91.36% to Rs. 110.26  millions from Rs. 57.62 millions.Operating profit surged to 264.08 millions from the corresponding previous quarter of 159.07 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 710.97 502.42 41.51 2517.36 1775.85 41.76 2517.36 1775.85 41.76
Other Income 1.71 1.82 -6.04 22.87 13.13 74.18 22.87 13.13 74.18
PBIDT 264.08 159.07 66.01 711.76 509.96 39.57 711.76 509.96 39.57
Interest 24.11 41.93 -42.50 78.56 85.35 -7.96 78.56 85.35 -7.96
PBDT 239.97 117.14 104.86 633.20 424.10 49.30 633.20 424.10 49.30
Depreciation 59.36 54.77 8.38 235.64 208.82 12.84 235.64 208.82 12.84
PBT 180.61 62.37 189.58 397.56 215.28 84.67 397.56 215.28 84.67
TAX 70.35 4.75 1381.05 92.71 40.25 130.34 92.71 40.25 130.34
Deferred Tax 8.06 4.75 69.68 30.41 40.25 -24.45 30.41 40.25 -24.45
PAT 110.26 57.62 91.36 304.85 175.03 74.17 304.85 175.03 74.17
Equity 222.50 219.50 1.37 222.50 219.50 1.37 222.50 219.50 1.37
PBIDTM(%) 37.14 31.66 17.32 28.27 28.72 -1.54 28.27 28.72 -1.54
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..